KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Minority Interest (2018 - 2021)

Guardant Health's Minority Interest history spans 4 years, with the latest figure at $59.4 million for Q3 2021.

  • On a quarterly basis, Minority Interest rose 5.32% to $59.4 million in Q3 2021 year-over-year; TTM through Sep 2021 was $59.4 million, a 5.32% increase, with the full-year FY2020 number at $57.1 million, up 15.12% from a year prior.
  • Minority Interest hit $59.4 million in Q3 2021 for Guardant Health, roughly flat from $59.4 million in the prior quarter.
  • Over the last five years, Minority Interest for GH hit a ceiling of $59.4 million in Q1 2021 and a floor of $41.8 million in Q4 2018.
  • Historically, Minority Interest has averaged $50.8 million across 4 years, with a median of $49.6 million in 2019.
  • Biggest five-year swings in Minority Interest: dropped 2.15% in 2020 and later soared 30.55% in 2021.
  • Tracing GH's Minority Interest over 4 years: stood at $41.8 million in 2018, then grew by 18.66% to $49.6 million in 2019, then rose by 15.12% to $57.1 million in 2020, then increased by 4.03% to $59.4 million in 2021.
  • Business Quant data shows Minority Interest for GH at $59.4 million in Q3 2021, $59.4 million in Q2 2021, and $59.4 million in Q1 2021.